Noman Paracha

6PUBLICATIONS
25CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 06, 2026
Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer.

Neal Shore, Alicia K Morgans, Noman Paracha

|Sep 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care.

Carsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas

|Jun 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis.

Ulrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas

|Jan 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data.

Carsten Bokemeyer, Noman Paracha, Ulrik Lassen

|Oct 18, 2021
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom.

Siu Hing Lo, Ksenija Gorni, C Simone Sutherland

|Feb 27, 2020
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis.

Noman Paracha, Adriana Reyes, Véronique Diéras

Pageof 1

Frequent Collaborators

3 joint publications

Carsten Bokemeyer

3 joint publications

Ulrik Lassen

3 joint publications

Antoine Italiano

3 joint publications

Jesus Garcia-Foncillas